# How to cope with Long COVID – A qualitative interview study on stressors and coping strategies of people affected by long-term consequences of COVID-19

**Authors:** Melanie Elgner, Marius Binneböse, Josi Großmann, Tamara Frank, Paul Bruckmann, Claas Lahmann, Katrin Elisabeth Giel, Christine Allwang, Florian Junne, Hannah Wallis

PMC · DOI: 10.1371/journal.pone.0343115 · PLOS One · 2026-02-23

## TL;DR

This study explores the stressors and coping strategies of people with Long COVID, highlighting the need for tailored support to manage symptoms and improve quality of life.

## Contribution

The study provides new insights into the diverse coping patterns and stressors experienced by individuals with Long COVID.

## Key findings

- Participants reported persistent physical and mental complaints, including fatigue and cognitive impairments.
- Emotional support was identified as the most frequently used coping strategy among individuals with Long COVID.
- Stressors such as job insecurity and lack of treatment were found to significantly impact participants' well-being.

## Abstract

Long COVID, a multi-system-disease characterized by persistent somatic and mental symptoms following a SARS-CoV-2 infection, can severely impair health and quality of life of those affected. In the absence of adequate therapeutic approaches and a fragmented care landscape, our focus is on identifying individual stressors, the resulting needs and strategies people use to cope with the ongoing burden of the disease and its long-term stressors. This qualitative interview study is part of a pilot multicenter study addressing psychosocial needs in patients with Long COVID. The surveyed sample (n = 40) consists of affected people, who suffer from persistent symptoms and psychosocial stress after a SARS-CoV-2 infection. Based on the Transactional Stress Model according to Lazarus and Folkman and the Brief COPE by Carver, the qualitative analysis of semi-structured interviews focused on the various and individual coping attempts of the interviewees. Participants reported a wide range of persistent physical and mental complaints. Fatigue-associated complaints, cognitive impairments, fears and worries were mentioned frequently and perceived as particularly stressful. Job insecurity and financial worries, lack of recognition, stigmatization, lack of treatment and therapy approaches, withdrawal and social isolation were reported as stressors. In most cases, we identified an interplay between emotion-oriented (such as emotional support, self-care and positive thinking) and problem-oriented coping strategies (such as planning/pacing, self-help, withdrawal and avoidance). Emotional support as the most frequently mentioned strategy and as a fundamental resource in coping with this disease should be strengthened. These findings offer a valuable insight into the diverse stressors and coping patterns in dealing with post-viral symptoms of COVID-19. The analysis reveals that complaints and attempts to cope vary significantly among the participants. This underlines the importance of providing tailored support to those affected to help them manage their symptoms, improve their quality of life and enable them to participate in social life again.

## Full-text entities

- **Diseases:** difficulty falling asleep (MESH:C537863), SSD (MESH:D000071896), hair loss (MESH:D000505), Fatigue (MESH:D005221), chest tightness (MESH:D002637), osteoarthritis (MESH:D010003), word-finding difficulties (MESH:D009461), fever (MESH:D005334), smell or taste disorder (MESH:D000857), Hashimoto's disease (MESH:D050031), anxiety disorders (MESH:D001008), concentration problems (MESH:C567712), difficulties (MESH:D051346), headache (MESH:D006261), vision deteriorated (MESH:D014786), sleep disorders (MESH:D012893), pain (MESH:D010146), insomnia (MESH:D007319), hyperhidrosis (MESH:D006945), breathing difficulties (MESH:D004417), dependency (MESH:D019966), Mental and behavioural disorders (MESH:D001523), tinnitus (MESH:D014012), cancer (MESH:D009369), weakness (MESH:D018908), Schizophrenia (MESH:D012559), anxiety (MESH:D001007), eye pressure, watery eyes (MESH:D005134), asthma (MESH:D001249), stomach problems (MESH:D013272), depression (MESH:D003866), palpitations (MESH:D006331), muscle and joint pain (MESH:D063806), schizotypal and delusional disorders (MESH:D012563), post-exertional malaise (MESH:D000092202), migraines (MESH:D008881), fog (MESH:D005222), cognitive disorders (MESH:D003072), ill (MESH:D002908), COVD-19 (MESH:D000094024), long-term sick (MESH:D000088562), Stress (MESH:D000079225), re-infection (MESH:D000084063), sore throat (MESH:D010612), hypertension (MESH:D006973), lack (MESH:D001259), back pain (MESH:D001416), burnout (MESH:D002055), coronavirus (MESH:D018352), infected (MESH:D007239), -term consequences of COVID-19 (MESH:D000086382), dry cough (MESH:D003371), dizziness (MESH:D004244), mental health disorder (OMIM:603663), loss of smell and taste (MESH:D000086582)
- **Chemicals:** Alcohol (MESH:D000438), psychoactive substance (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12928408/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12928408/full.md

## References

44 references — full list in the complete paper: https://tomesphere.com/paper/PMC12928408/full.md

---
Source: https://tomesphere.com/paper/PMC12928408